Introduction

A critically ill patient is not simply a hospital patient who happens to be sicker. Critical illness is a state in which one or more vital organ systems are unstable or failing, and the body’s normal regulation of oxygen delivery, inflammation, substrate use, fluid balance, and protein turnover is disrupted. In this setting, nutrition support is not “meal planning.” It is a clinical therapy delivered into a changing physiologic system.

At the bedside, the question is rarely, “How many calories does this patient need?” The better first question is:

What is happening to this patient today, and what form of nutrition can be delivered safely while supporting recovery rather than adding harm?

This book is built around that question.

Critical care nutrition sits at the intersection of metabolism, gastrointestinal physiology, vascular perfusion, organ support, medication therapy, infection risk, and rehabilitation. Guidelines from ASPEN/SCCM and ESPEN emphasize that nutrition support in the intensive care unit should be assessed, prescribed, delivered, and monitored as part of the larger critical care plan rather than as an isolated order for calories and protein (McClave et al., 2016; Singer et al., 2019; Compher et al., 2022). This is especially true when patients are mechanically ventilated, receiving vasopressors, developing acute kidney injury, undergoing renal replacement therapy, recovering from surgery or trauma, or transitioning from shock to rehabilitation.

This introduction gives the first orientation: what critical care nutrition is, why it is difficult, and how the chapters ahead will train you to make medication-aware enteral and parenteral nutrition decisions at the bedside.

Nutrition support as a clinical intervention

A nutrient is a substance the body can use for energy, structure, regulation, or biochemical function. Glucose, amino acids, fatty acids, electrolytes, vitamins, and trace elements are all nutrients. In routine health, nutrients arrive mainly through oral eating, digestion, absorption, distribution in the blood, cellular uptake, and metabolism.

In critical illness, each step can be altered.

A patient with septic shock may have impaired gut perfusion. A patient with acute respiratory distress syndrome may be sedated, ventilated, and unable to eat. A patient receiving propofol may receive a meaningful lipid calorie load from medication before any enteral formula is prescribed. A patient on continuous renal replacement therapy may lose amino acids and water-soluble micronutrients through the extracorporeal circuit. A patient with severe malnutrition may develop refeeding syndrome if carbohydrate delivery is advanced too aggressively.

For this reason, nutrition support means more than providing food. It means delivering nutrients by a planned medical route when ordinary oral intake is insufficient or unsafe. The two central routes are enteral nutrition and parenteral nutrition.

Enteral nutrition, often abbreviated EN, is nutrition delivered into the gastrointestinal tract, usually through a feeding tube. The tube may end in the stomach, duodenum, or jejunum. EN uses the gut as the route of nutrient delivery. For example, a ventilated patient who cannot eat but has a functioning gastrointestinal tract may receive a continuous high-protein formula through a nasogastric tube.

Parenteral nutrition, often abbreviated PN, is nutrition delivered intravenously, bypassing the gastrointestinal tract. PN contains amino acids, dextrose, lipid injectable emulsion, electrolytes, vitamins, trace elements, and water in a sterile formulation. For example, a patient with bowel ischemia or prolonged severe ileus may require PN because feeding into the gut is unsafe or ineffective.

Neither EN nor PN is automatically “better” in every circumstance. EN is generally preferred when the gastrointestinal tract is usable because it is physiologic and is supported by major critical care nutrition guidelines, but EN can be dangerous in selected patients with uncontrolled shock, bowel ischemia, obstruction, abdominal compartment syndrome, or severe gastrointestinal intolerance (McClave et al., 2016; Reintam Blaser et al., 2017; Singer et al., 2019). PN can be lifesaving when the gut cannot be used, but it requires careful control of glucose, fluid, electrolytes, sterility, lipid exposure, and micronutrient provision. Trials and guidelines show that timing, patient selection, nutrition risk, and dose matter; PN should not be treated as a simple substitute for missed tube feeding (Casaer et al., 2011; Compher et al., 2022).

The specialist task is therefore not to defend one route as universally superior. The task is to choose the safest route, dose, timing, and monitoring plan for the patient’s current phase of illness.

Why the ICU changes the rules

In ordinary nutrition assessment, clinicians often begin with habitual intake, body weight, weight loss, dietary pattern, and chronic disease history. These still matter in the ICU, but they are not enough.

Critical illness changes the body’s metabolic priorities. Metabolism is the total set of chemical processes by which the body transforms substrates such as glucose, fatty acids, and amino acids into energy, structural molecules, and signaling molecules. During severe infection, trauma, burns, or shock, inflammatory and neuroendocrine signals can increase protein breakdown, alter glucose handling, increase insulin resistance, and shift substrate use. The visible bedside result may be rapid muscle loss even while the patient appears fluid overloaded rather than thin.

A simple example makes this clear. Suppose two patients each weigh 80 kg. One is recovering from elective surgery and eating poorly for two days. The other has septic shock, mechanical ventilation, acute kidney injury, rising vasopressor requirements, and generalized edema. Their body weights are the same, but their nutrition decisions are not. The second patient’s weight is distorted by fluid accumulation; his gut perfusion may be unstable; his protein catabolism may be high; his medications may add calories or change electrolyte balance; and his nutrition prescription must be integrated with shock management, ventilation, renal support, and glycemic control.

This is why ICU nutrition assessment must be structured. It must ask about diagnosis, severity of illness, pre-illness nutrition status, muscle and functional reserve, gastrointestinal function, hemodynamics, medications, laboratory trends, fluid balance, and organ support. Tools such as the NUTRIC score and modified NUTRIC score were developed to help identify critically ill patients who may be at higher nutrition risk and potentially more likely to benefit from adequate nutrition therapy, although such tools support clinical judgment rather than replace it (Heyland et al., 2011; McClave et al., 2016).

The bedside problem of feeding during vasopressor therapy

One of the most difficult ICU nutrition decisions is whether to feed a patient receiving vasopressors.

A vasopressor is a medication that increases arterial blood pressure primarily by increasing vascular tone, cardiac output, or both. Common ICU examples include norepinephrine, epinephrine, vasopressin, phenylephrine, and dopamine. Vasopressors are often used in shock, a state in which tissue perfusion is inadequate for the body’s needs. In septic shock, for example, vasopressors are used when fluids alone do not restore adequate mean arterial pressure and perfusion; contemporary sepsis guidelines emphasize prompt resuscitation and vasopressor support when indicated (Evans et al., 2021).

The nutrition question arises because the gut is not just a tube. It is a living organ that needs blood flow. Feeding into the gastrointestinal tract increases digestive activity and oxygen demand. If intestinal perfusion is severely compromised, enteral feeding may worsen intolerance or, in rare but serious cases, contribute to bowel ischemia. Bowel ischemia means inadequate blood supply to the intestine, which can progress to tissue injury, necrosis, perforation, sepsis, and death.

This does not mean that every patient on norepinephrine must be kept without enteral nutrition. It means that vasopressor therapy must be interpreted in context.

Consider two patients:

• Patient A is receiving a low, stable norepinephrine dose after initial septic shock resuscitation. Lactate is decreasing, mean arterial pressure is stable, urine output is improving, and there is no abdominal distension. This patient may be a candidate for cautious trophic enteral feeding.
• Patient B is receiving rapidly escalating norepinephrine plus vasopressin, lactate is rising, skin is mottled, abdominal distension is worsening, and acidosis is deepening. This patient is not simply “on vasopressors”; this patient has ongoing unstable shock. Enteral feeding should generally be held while perfusion is restored and bowel ischemia is considered.

Trophic feeding means a small amount of enteral nutrition given primarily to stimulate and maintain gut function rather than to meet full calorie and protein goals. It is sometimes used as a cautious starting strategy in patients who are improving but not yet ready for full feeding. The key is that trophic feeding is not neglect; it is a deliberate low-dose intervention matched to physiologic uncertainty.

Evidence supports caution. The ESICM guideline on early enteral nutrition advises delaying EN in uncontrolled shock but considering low-dose EN after shock is controlled with fluids and vasopressors or inotropes (Reintam Blaser et al., 2017). In the NUTRIREA-2 trial, mechanically ventilated adults with shock receiving vasopressors were assigned to early isocaloric enteral or parenteral nutrition; mortality did not differ significantly, but the enteral group had more gastrointestinal complications, including bowel ischemia and acute colonic pseudo-obstruction (Reignier et al., 2018). This trial does not prove that all EN during vasopressor therapy is unsafe, but it strongly teaches that dose, timing, shock severity, and gastrointestinal warning signs matter.

Chapter 7 will develop this into a practical framework: assess shock trajectory, vasopressor dose and direction, lactate trend, perfusion markers, abdominal examination, gastrointestinal output, surgical risk, and alternative nutrition routes before deciding whether to start, hold, or advance EN.

Medication-aware nutrition

In the ICU, medications are not separate from nutrition. They can contribute calories, alter metabolism, change gastrointestinal motility, modify electrolyte needs, and interact with tube feeding.

Medication-aware nutrition means that the nutrition prescription is designed after actively reviewing the medication profile. The feeding plan is not complete until medication effects have been counted.

For example, propofol is formulated in a lipid emulsion and can provide a clinically important non-nutritive calorie load. If the nutrition team ignores propofol calories, the patient may be overfed, especially if full enteral or parenteral calories are also prescribed. Dextrose-containing infusions may add carbohydrate calories. Insulin therapy changes the safe rate of dextrose delivery. Corticosteroids may worsen hyperglycemia and promote protein catabolism. Prokinetic medications may be used to improve gastric emptying. Some medications, such as levothyroxine or certain antimicrobials, may require attention to timing around enteral feeding depending on formulation, absorption concerns, and local pharmacy guidance.

A bedside example is common: a ventilated patient with ARDS is receiving propofol, norepinephrine, insulin infusion, broad-spectrum antibiotics, and enteral nutrition. The feeding order says 60 mL/hour of an energy-dense formula. But the patient is also receiving several hundred kilocalories per day from propofol. The glucose infusion rate from PN or dextrose-containing fluids may be too high for current insulin needs. The norepinephrine dose may be decreasing, suggesting that cautious EN advancement is possible, or increasing, suggesting that feeding should pause. The nutrition decision depends on the whole medication-nutrition picture, not on formula selection alone.

This book returns to this theme repeatedly. The feeding route, formula, infusion rate, macronutrient distribution, electrolyte content, glucose plan, lipid exposure, and monitoring schedule must all be reconciled with active medications.

Avoiding both underfeeding and overfeeding

A central danger in ICU nutrition is to think that more nutrition is always better. Another danger is to accept prolonged near-starvation because the patient is unstable. Both can be harmful.

Underfeeding means delivering substantially less energy, protein, or micronutrients than the patient requires over a clinically important period. In the ICU, underfeeding may occur because feeds are repeatedly interrupted for procedures, gastric residual checks, extubation attempts, proning, imaging, operating room transfers, or medication timing. Protein underdelivery is especially important because critical illness is often highly catabolic, meaning the body breaks down its own tissues, including skeletal muscle, to provide amino acids and energy substrates.

Overfeeding means delivering more energy than the patient can safely oxidize or store. Overfeeding can worsen hyperglycemia, increase carbon dioxide production, promote hepatic fat accumulation, increase triglycerides, and complicate fluid or electrolyte management. PN and non-nutritive calories make overfeeding particularly easy if the prescription is not carefully calculated.

The solution is not a fixed calorie number for every patient. The solution is staged, monitored feeding. Early in shock or acute severe inflammation, the patient may need cautious initiation rather than full feeding. As hemodynamics stabilize and the patient enters a recovery or anabolic phase, protein delivery, rehabilitation nutrition, and oral or enteral transition become increasingly important. Indirect calorimetry, when available and valid, is the preferred method for measuring energy expenditure in many critically ill patients because predictive equations can be inaccurate in the ICU (Singer et al., 2019; Compher et al., 2022).

A simple clinical pattern illustrates the point. On ICU day 1, a patient in septic shock may receive no EN or only trophic EN while vasopressors escalate. On ICU day 3, vasopressors are decreasing and lactate is improving; EN may advance cautiously with close monitoring. On ICU day 7, shock has resolved but the patient is profoundly weak; the priority shifts toward achieving protein targets, reducing unnecessary interruptions, planning swallowing assessment, and supporting rehabilitation. The “right” nutrition prescription changes because the patient’s phase of illness changes.

What this book will teach you to do

This book follows the patient from first ICU assessment to recovery planning. It begins with the physiology of critical illness because safe feeding requires understanding the system being fed. It then builds a structured nutrition assessment: diagnosis, severity of illness, nutrition history, anthropometry, body composition clues, functional status, laboratory trends, fluid balance, gastrointestinal function, and nutrition risk tools.

After assessment, the book turns to prescription. You will learn how to estimate or measure energy expenditure, set protein targets, interpret indirect calorimetry, use predictive equations cautiously, and adjust for obesity, renal replacement therapy, burns, trauma, liver disease, and respiratory failure. You will learn how to select enteral formulas, choose gastric or post-pyloric access, design feeding advancement schedules, and troubleshoot intolerance.

The middle chapters focus on the most hazardous bedside decisions: feeding during vasopressor therapy, managing gastrointestinal complications, deciding when PN is indicated, and designing safe PN prescriptions. Later chapters integrate medication-nutrition interactions, non-nutritive calories, glucose control, lipid exposure, refeeding syndrome, organ failure, specialized populations, protocols, case-based reasoning, and transition from ICU feeding to rehabilitation and discharge.

The goal is not memorization of isolated targets. The goal is a repeatable clinical method:

1. Understand the current phase of critical illness.
2. Assess nutrition risk and baseline reserve.
3. Determine whether the gut can be used safely.
4. Choose EN, PN, oral nutrition, or a staged combination.
5. Account for medications and non-nutritive calories.
6. Start at a dose appropriate to physiologic stability.
7. Monitor tolerance, metabolism, electrolytes, fluid, and organ support daily.
8. Advance, hold, reduce, or transition nutrition as the patient changes.

These steps sound simple, but in real ICU practice they require disciplined interpretation. A feeding order is only safe when it matches the patient’s hemodynamics, gastrointestinal function, medication exposure, metabolic tolerance, and goals of care.

The clinical attitude of this book

Critical care nutrition rewards humility. Many ICU nutrition questions have imperfect evidence, and trials often study broad populations while bedside patients present with complex combinations of shock, organ failure, malnutrition, obesity, surgery, medications, and treatment limitations. Guidelines provide essential boundaries, but they do not remove the need for clinical judgment.

The safest approach is neither aggressive feeding nor reflexive fasting. It is physiologic feeding: nutrition matched to perfusion, gut function, metabolic capacity, nutrition risk, and trajectory of illness.

When the patient is unstable, ask what must be protected first. When the patient is improving, ask what can be advanced safely. When the patient is recovering, ask how nutrition can support strength, function, and continuity beyond the ICU.

That is the pathway this book will build: assessment first, route selection second, prescription third, monitoring always, and medication awareness throughout.

References

Casaer, M. P., Mesotten, D., Hermans, G., Wouters, P. J., Schetz, M., Meyfroidt, G., Van Cromphaut, S., Ingels, C., Meersseman, P., Muller, J., Vlasselaers, D., Debaveye, Y., Desmet, L., Dubois, J., Van Assche, A., Vanderheyden, S., Wilmer, A., & Van den Berghe, G. (2011). Early versus late parenteral nutrition in critically ill adults. The New England Journal of Medicine, 365(6), 506–517.

Compher, C., Bingham, A. L., McCall, M., Patel, J., Rice, T. W., Braunschweig, C., & McKeever, L. (2022). Guidelines for the provision of nutrition support therapy in the adult critically ill patient: The American Society for Parenteral and Enteral Nutrition. JPEN Journal of Parenteral and Enteral Nutrition, 46(1), 12–41.

Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., McIntyre, L., Ostermann, M., Prescott, H. C., Schorr, C., Simpson, S., Wiersinga, W. J., Alshamsi, F., Angus, D. C., Arabi, Y., Azevedo, L., Beale, R., Beilman, G., Belley-Cote, E., … Levy, M. (2021). Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock 2021. Intensive Care Medicine, 47, 1181–1247.

Heyland, D. K., Dhaliwal, R., Jiang, X., & Day, A. G. (2011). Identifying critically ill patients who benefit the most from nutrition therapy: The development and initial validation of a novel risk assessment tool. Critical Care, 15(6), R268.

McClave, S. A., Taylor, B. E., Martindale, R. G., Warren, M. M., Johnson, D. R., Braunschweig, C., McCarthy, M. S., Davanos, E., Rice, T. W., Cresci, G. A., Gervasio, J. M., Sacks, G. S., Roberts, P. R., Compher, C., & Society of Critical Care Medicine; American Society for Parenteral and Enteral Nutrition. (2016). Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient. JPEN Journal of Parenteral and Enteral Nutrition, 40(2), 159–211.

Reignier, J., Boisramé-Helms, J., Brisard, L., Lascarrou, J. B., Ait Hssain, A., Anguel, N., Argaud, L., Asehnoune, K., Asfar, P., Bellec, F., Botoc, V., Bretagnol, A., Bui, H. N., Canet, E., Da Silva, D., Darmon, M., Das, V., Devaquet, J., Djibre, M., Ganster, F., … NUTRIREA-2 Trial Investigators. (2018). Enteral versus parenteral early nutrition in ventilated adults with shock: A randomised, controlled, multicentre, open-label, parallel-group study. The Lancet, 391(10116), 133–143.

Reintam Blaser, A., Starkopf, J., Alhazzani, W., Berger, M. M., Casaer, M. P., Deane, A. M., Fruhwald, S., Hiesmayr, M., Ichai, C., Jakob, S. M., Loudet, C. I., Malbrain, M. L. N. G., Montejo González, J. C., Paugam-Burtz, C., Poeze, M., Preiser, J. C., Singer, P., van Zanten, A. R. H., De Waele, J., & Wendon, J. (2017). Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines. Intensive Care Medicine, 43(3), 380–398.

Singer, P., Blaser, A. R., Berger, M. M., Alhazzani, W., Calder, P. C., Casaer, M. P., Hiesmayr, M., Mayer, K., Montejo, J. C., Pichard, C., Preiser, J. C., van Zanten, A. R. H., Oczkowski, S., Szczeklik, W., & Bischoff, S. C. (2019). ESPEN guideline on clinical nutrition in the intensive care unit. Clinical Nutrition, 38(1), 48–79.